Ads
-
Related paper
- Methods of pharmacological correction of intrauterine growth restriction syndrome
- Role of Foetal Biometry and Doppler Studies in the Evaluation of Intrauterine Growth Restriction
- Accuracy of Cerebroumblical Pulsatility Index Ratio in Intrauterine Growth Restriction in Third Trimester as a Predictor of Adverse Perinatal Outcome
- Accuracy of Cerebroumblical Pulsatility Index Ratio in Intrauterine Growth Restriction in Third Trimester as a Predictor of Adverse Perinatal Outcome
- The Prediction of Adverse Perinatal Outcomes in Intrauterine Growth Restriction using the Doppler Indices of Myocardial Performance and Aortic Isthmus
- Value of Middle Cerebral/Umbilical Artery Resistance Index Ratio in Neonatal Outcome in Patients with Intrauterine Growth Restriction (A Prospective Study)
- Alteration in 11 Beta-Hydroxysteroid Dehydrogenase Type-2 (HSD11B2) Gene as A Potential Candidate Parameter for Early Detection of Intrauterine Growth Restriction (IUGR) Events
- Clinical and Pathogenetical Peculiarities of the Secondary Raynaud’s Syndrome and Their Pharmacological Correction
- PERNICIOUS HABITS AS FACTOR OF EMERGENCE OF THE SYNDROME OF THE INTRAUTERINE GROWTH RETARDATION
- Age-Related Features of Detectability of Xenobiotic Enzyme Gene Polymorphism in Pregnant Women with Fetal Growth Restriction Syndrome |Biomedgrid